SFA |
➢Contribute to metabolic diseases (T2DM and obesity)10.➢Induces insulin resistance, ER stress, and inflammation20,25. |
➢Correlate to greater age, burn severity, and mortality.➢May have anti-inflammatory roles (e.g. palmitate). |
MuFA |
➢Cardioprotective, reduces insulin resistance, and improves wound healing12,28
|
➢Early mobilization may be physiological and beneficial.➢Persistent elevation correlated to increased mortality. |
w-3 PuFA |
➢Anti-inflammatory and immune resolution11.➢Precursors to special pro-resolving mediators (SPM), i.e. resolvins30. |
➢Variable effect on inflammation.➢Pro-inflammatory responses from w-6 derivatives. |
w-6 PuFA |
➢Mediates inflammation and pain29.➢Precursors to special pro-resolving mediators (SPM), i.e. lipoxins30. |
➢Anti-inflammatory effect potentially mediated via SPMs.➢Not necessary/sufficient for sepsis. |